IMMUNOX 1 GM

Product Specification: Immunox

Manufacturer: Venus Remedies

Product Description:

Name: Immunox
Form: Injection
Dosage Strength: 1 gm
Composition: Ceftriaxone Injection 1 GM
Presentation: Vial

Visit Us on Indiamart

*****

Advance Information*

IMMUNOX 1 GM: Comprehensive Product Description

IMMUNOX 1 GM, a premier pharmaceutical product from Venus Remedies, represents the epitome of advanced antibiotic therapy aimed at eradicating severe bacterial infections. This potent formulation contains Ceftriaxone, a third-generation cephalosporin antibiotic known for its remarkable efficacy and broad-spectrum antibacterial activity. Ensuring patient safety and therapeutic success, IMMUNOX 1 GM aligns with stringent pharmaceutical standards, making it a trusted choice in clinical settings worldwide.

Product Overview

Name:

IMMUNOX

Form:

Injection

Dosage Strength:

1 gm

Composition:

Ceftriaxone Injection 1 GM

Presentation:

Vial

IMMUNOX is meticulously crafted to deliver optimal therapeutic outcomes through a highly refined formulation process. The 1 gm dosage strength ensures that each administration provides a potent concentration of Ceftriaxone, capable of tackling severe infections with precision and efficacy. Below, we delve into various aspects of IMMUNOX 1 GM, including its detailed mechanism of action, clinical indications, administration routes, dosage guidelines, and other critical attributes essential for healthcare professionals.

Mechanism of Action

Ceftriaxone, the active ingredient in IMMUNOX 1 GM, exhibits its therapeutic effects primarily by targeting bacterial cell wall synthesis. The process involves the following steps:

1. Inhibition of Bacterial Cell Wall Synthesis:
2. Ceftriaxone binds to penicillin-binding proteins (PBPs) located in the bacterial cell wall.
3. This binding disrupts the final stages of peptidoglycan synthesis, crucial for cell wall integrity.

4. The interruption of peptidoglycan cross-linking weakens the bacterial cell wall, rendering the bacteria unable to maintain structural stability.

5. Bactericidal Action:

6. The compromised cell wall structure leads to osmotic imbalance and ultimately bacterial cell lysis and death.
7. Ceftriaxone’s broad-spectrum activity targets a wide range of Gram-positive and Gram-negative bacteria, ensuring comprehensive coverage against resistant pathogens.

Indications

IMMUNOX 1 GM is indicated for the treatment of a variety of serious bacterial infections, including but not limited to:

• Severe Respiratory Tract Infections:

• Effective against pathogens causing pneumonia, bronchitis, and other lower respiratory tract infections.

• Urinary Tract Infections (UTIs):

• Addresses complicated and uncomplicated UTIs, including pyelonephritis.

• Skin and Soft Tissue Infections:

• Potent action against cellulitis, abscesses, and wound infections.

• Bacterial Meningitis:

• Crosses the blood-brain barrier to treat central nervous system infections.

• Gonorrhea:

• Recommended for sexually transmitted infections, particularly Neisseria gonorrhoeae.

• Lyme Disease:

• Effective in various stages of Borrelia burgdorferi-induced conditions.

• Intra-abdominal Infections:

• Combats infections such as peritonitis.

• Septicemia:

• Aids in managing bloodstream infections and sepsis.

Administration and Dosage

IMMUNOX 1 GM can be administered via the following routes based on clinical need and patient condition:

• Intravenous (IV) Administration:
• Directly delivered into the bloodstream for rapid and systemic action.

• Suitable for severe infections requiring immediate therapeutic levels.

• Intramuscular (IM) Administration:

• Injected into muscle tissue for slower absorption and prolonged plasma concentration.
• Often used in outpatient settings or for conditions where gradual drug release is beneficial.

Dosage Guidelines

1. Adult Dosage:
2. The typical adult dosage ranges between 1-2 grams per day, depending on infection severity and patient response.

3. In severe cases, the dosage may be escalated up to 4 grams per day, administered in divided doses.

4. Pediatric Dosage:

5. Pediatric dosing is generally weight-based, typically 50-75 mg/kg/day, administered in divided doses.

6. Neonatal Dosage:

7. For neonates, the recommended dosage varies from 20-50 mg/kg/day based on specific medical indications.

Healthcare professionals should always tailor dosage regimens based on individual patient factors, including renal and hepatic function, the severity of infection, and concomitant medical conditions.

Pharmacokinetics and Pharmacodynamics

1. Absorption:

2. Ceftriaxone is fully bioavailable when administered via intravenous or intramuscular routes.

3. Distribution:

4. The drug exhibits extensive distribution across body fluids and tissues.
5. Notable for crossing the blood-brain barrier and achieving therapeutic concentrations in cerebro